Manglende evidens i forebyggelse af kemoterapiinduceret kvalme og opkastning hos børn og unge

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Manglende evidens i forebyggelse af kemoterapiinduceret kvalme og opkastning hos børn og unge. / Eliasen, Astrid; Callesen, Michael Thude; Dalhoff, Kim Peder; Rechnitzer, Catherine; Schmiegelow, Kjeld; Schrøder, Henrik; Tuckuviene, Ruta; Holst, Helle.

I: Ugeskrift for Laeger, Bind 180, Nr. 35, V11170851, 2018.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Eliasen, A, Callesen, MT, Dalhoff, KP, Rechnitzer, C, Schmiegelow, K, Schrøder, H, Tuckuviene, R & Holst, H 2018, 'Manglende evidens i forebyggelse af kemoterapiinduceret kvalme og opkastning hos børn og unge', Ugeskrift for Laeger, bind 180, nr. 35, V11170851. <http://ugeskriftet.dk/videnskab/manglende-evidens-i-forebyggelse-af-kemoterapiinduceret-kvalme-og-opkastning-hos-boern-og>

APA

Eliasen, A., Callesen, M. T., Dalhoff, K. P., Rechnitzer, C., Schmiegelow, K., Schrøder, H., Tuckuviene, R., & Holst, H. (2018). Manglende evidens i forebyggelse af kemoterapiinduceret kvalme og opkastning hos børn og unge. Ugeskrift for Laeger, 180(35), [V11170851]. http://ugeskriftet.dk/videnskab/manglende-evidens-i-forebyggelse-af-kemoterapiinduceret-kvalme-og-opkastning-hos-boern-og

Vancouver

Eliasen A, Callesen MT, Dalhoff KP, Rechnitzer C, Schmiegelow K, Schrøder H o.a. Manglende evidens i forebyggelse af kemoterapiinduceret kvalme og opkastning hos børn og unge. Ugeskrift for Laeger. 2018;180(35). V11170851.

Author

Eliasen, Astrid ; Callesen, Michael Thude ; Dalhoff, Kim Peder ; Rechnitzer, Catherine ; Schmiegelow, Kjeld ; Schrøder, Henrik ; Tuckuviene, Ruta ; Holst, Helle. / Manglende evidens i forebyggelse af kemoterapiinduceret kvalme og opkastning hos børn og unge. I: Ugeskrift for Laeger. 2018 ; Bind 180, Nr. 35.

Bibtex

@article{c18abbf6086f43b994b826fa22da280c,
title = "Manglende evidens i forebyggelse af kemoterapiinduceret kvalme og opkastning hos b{\o}rn og unge",
abstract = "Nausea and vomiting are burdensome side effects of chemotherapy. Vomiting is observed in up to 60% of treated children. An appropriate and effective antiemetic regimen has the potential to eradicate or reduce the symptoms. Differences in local guidelines characterise the antiemetic treatment across the four Danish paediatric oncology departments because the overall knowledge of the most effective antiemetics is incomplete. There is an unmet need for research, which can promote evidence-based guidelines. The impact of host genome polymorphisms should be included in the research.",
author = "Astrid Eliasen and Callesen, {Michael Thude} and Dalhoff, {Kim Peder} and Catherine Rechnitzer and Kjeld Schmiegelow and Henrik Schr{\o}der and Ruta Tuckuviene and Helle Holst",
year = "2018",
language = "Dansk",
volume = "180",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "35",

}

RIS

TY - JOUR

T1 - Manglende evidens i forebyggelse af kemoterapiinduceret kvalme og opkastning hos børn og unge

AU - Eliasen, Astrid

AU - Callesen, Michael Thude

AU - Dalhoff, Kim Peder

AU - Rechnitzer, Catherine

AU - Schmiegelow, Kjeld

AU - Schrøder, Henrik

AU - Tuckuviene, Ruta

AU - Holst, Helle

PY - 2018

Y1 - 2018

N2 - Nausea and vomiting are burdensome side effects of chemotherapy. Vomiting is observed in up to 60% of treated children. An appropriate and effective antiemetic regimen has the potential to eradicate or reduce the symptoms. Differences in local guidelines characterise the antiemetic treatment across the four Danish paediatric oncology departments because the overall knowledge of the most effective antiemetics is incomplete. There is an unmet need for research, which can promote evidence-based guidelines. The impact of host genome polymorphisms should be included in the research.

AB - Nausea and vomiting are burdensome side effects of chemotherapy. Vomiting is observed in up to 60% of treated children. An appropriate and effective antiemetic regimen has the potential to eradicate or reduce the symptoms. Differences in local guidelines characterise the antiemetic treatment across the four Danish paediatric oncology departments because the overall knowledge of the most effective antiemetics is incomplete. There is an unmet need for research, which can promote evidence-based guidelines. The impact of host genome polymorphisms should be included in the research.

M3 - Tidsskriftartikel

C2 - 30152323

VL - 180

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 35

M1 - V11170851

ER -

ID: 219534279